Evidence map›Paper›PMID 41862508›Full record

ArticleNature communications2026

A disease-agnostic approach to ensemble learning for infectious disease forecasting.

Alexander C Murph, Lauren J Beesley, G Casey Gibson, Lauren A Castro, Sara Y Del Valle, Dave Osthus

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alexander C Murph *Statistics (CAI-4), Computing and Artificial Intelligence Division, Los Alamos National Laboratory, Los Alamos, NM, USA. murph@lanl.gov.ORCID http://orcid.org/0000-0001-7170-867X
Lauren J Beesley *Statistics (CAI-4), Computing and Artificial Intelligence Division, Los Alamos National Laboratory, Los Alamos, NM, USA. lvandervort@lanl.gov.
G Casey GibsonStatistics (CAI-4), Computing and Artificial Intelligence Division, Los Alamos National Laboratory, Los Alamos, NM, USA.ORCID http://orcid.org/0000-0002-0370-9846
Lauren A CastroInformation Systems & Modeling (A-1), Analytics, Intelligence, & Technology Division, Los Alamos National Laboratory, Los Alamos, NM, USA.ORCID http://orcid.org/0000-0002-9778-570X
Sara Y Del ValleInformation Systems & Modeling (A-1), Analytics, Intelligence, & Technology Division, Los Alamos National Laboratory, Los Alamos, NM, USA.
Dave OsthusStatistics (CAI-4), Computing and Artificial Intelligence Division, Los Alamos National Laboratory, Los Alamos, NM, USA.ORCID http://orcid.org/0000-0002-4681-091X

Funding

DOE | LDRD | Los Alamos National Laboratory (Los Alamos Lab) 0240066DR
6 · The paper itself

Abstract

Accurate forecasting of infectious diseases drives modern public health interventions that reduce morbidity and mortality. However, accurate forecasting in real-time remains a challenge for the modeling community. Ensembling has emerged as a critical tool for accurate forecasting by leveraging multiple component (individual) models into a single weighted average. Traditional ensembling strategies have relied on bespoke component models that weight the contributions of individual models according to extensive historical data for specific diseases. This is impractical for an emerging disease, since there would be very little - if any - data. We propose an ensembling strategy, called epiFFORMA, that determines component weights for an ensemble model without historical data and is therefore disease-agnostic. The epiFFORMA model builds upon the FFORMA model from the M4 forecasting competition to harness epidemiological dynamics through synthetic data. We demonstrate that epiFFORMA performs better than a naive, equal-weighting ensembling strategy when forecasting outbreaks of COVID-19, diphtheria, influenza-like illness, dengue, measles, mumps, polio, rubella, smallpox, and chikungunya. We further show that epiFFORMA, on average, performs better than the individual component models in the ensemble.

Indexed as

Communicable DiseasesCOVID-19DengueDisease OutbreaksEnsemble LearningForecastingHumansInfluenza, HumanPandemicsPoliomyelitisPrediction AlgorithmsSARS-CoV-2Smallpox

Identifiers

PMID41862508
PMCPMC13168361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.